Appetite hormone misfires in obese people

Glucagon, a hormone involved in regulating appetite, loses its ability to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

The primary role of glucagon, a secreted by the pancreas, is to signal the body to release stored glucose when blood sugar falls too low. But growing evidence suggests the hormone also may play a role in controlling food intake and feelings of fullness, or satiation, through signaling the body to reduce levels of other appetite hormones like ghrelin.

"Once a person becomes obese, glucagon no longer induces feelings of fullness," said the study's lead author, Ayman M. Arafat, MD, of Charité-University Medicine in Berlin, Germany. "Further research is needed to determine why glucagon no longer suppresses appetite effectively in this population, even though they are otherwise healthy."

The prospective, double-blinded, placebo-controlled study investigated glucagon levels and appetite among 11 , 13 people with and 13 lean people. Participants received injections of either glucagon or a placebo. Researchers then measured participants' appetites using a satiety scale as well as levels of the hormone ghrelin.

Feelings of fullness did not differ between obese study participants who received glucagon injections and those who were given the placebo. In comparison, participants who were lean or had type 1 reported feeling significantly more full after receiving glucagon. The response to the hormone was detectable in this population, even 24 hours after it was administered.

"The findings could influence efforts to develop new treatments for obesity and diabetes," Arafat said. "Although therapeutic agents that influence glucagon and other hormones currently are considered a promising avenue for research, this study suggests a treatment involving may be ineffective in controlling meal size in people who are obese."

More information: The article, "The Impact of Insulin-independent Glucagon-induced Suppression of Total-Ghrelin on Satiety in Obesity and Type 1 Diabetes Mellitus," was published online Aug. 20.

Related Stories

New findings on glucagon synthesis

Dec 03, 2012

Researchers at Karolinska Institutet in Sweden have shown that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin. ...

Recommended for you

Gut bacteria promote obesity in mice

Sep 30, 2014

A species of gut bacteria called Clostridium ramosum, coupled with a high-fat diet, may cause animals to gain weight. The work is published this week in mBio, the online open-access journal of the American Society for Microbiol ...

An apple a day could keep obesity away

Sep 29, 2014

Scientists at Washington State University have concluded that nondigestible compounds in apples – specifically, Granny Smith apples – may help prevent disorders associated with obesity. The study, thought ...

Boosting purchasing power to lower obesity rates

Sep 25, 2014

In January, as one of the first major initiatives of the Academic Vision, the Rudd Center for Food Policy and Obesity will move to UConn from Yale University. The move will allow Rudd faculty to expand their work and build ...

Note to young men: Fat doesn't pay

Sep 23, 2014

Men who are already obese as teenagers could grow up to earn up to 18 percent less than their peers of normal weight. So says Petter Lundborg of Lund University, Paul Nystedt of Jönköping University and ...

Waistlines of US adults continue to increase

Sep 16, 2014

The prevalence of abdominal obesity and average waist circumference increased among U.S. adults from 1999 to 2012, according to a study in the September 17 issue of JAMA.

User comments